Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases

Clinical and Experimental Metastasis

Volumn 16, Issue 6, 1998, Pages 501-512

  Kelly, Thomas ^a   Yan, Yan ^a   Osborne, Rebecca L ^a   Athota, Anupama B ^a   Rozypal, Tricia L ^a   Colclasure, J Chris ^a   Chu, Winston S ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

(BB 94) batimastat; Fibronectin; Invadopodia; Invasion; Metastasis; MMP

Indexed keywords

BATIMASTAT; MATRIX METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PROTEIN DEGRADATION;

BREAST NEOPLASMS; COLLAGEN; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FEMALE; FIBRONECTINS; HUMANS; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PHENYLALANINE; PSEUDOPODIA; THIOPHENES; TUMOR CELLS, CULTURED;

EID: 0032430209     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006538200886     Document Type: Article

References (42)

1. Mignatti P and Rifkin DB, 1993, Biology and biochemistry of proteinases in tumor invasion. Phvsiol Revs, 73, 161-95.
2. Stetler-Stevenson WG, Aznavoorian S and Liotta LA, 1993, Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol, 9, 541-73.
3. Chen WT, 1996, Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enz and Prot, 49, 59-71.
4. Chen W-T, Olden K, Bernard BA and Chu F-F, 1984, Expression of transformation-associated protease(s) that degrade fibronectin at cell contact sites. J Cell Biol, 98, 1546-55.
5. Kelly T, Mueller SC, Yeh Y and Chen W-T, 1994, Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J Cell Physiol, 158, 299-308.
6. Chen W-T, 1989, Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J Exp Zool, 251, 167-85.
7. Aoyama A and Chen W-T, 1990, A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc Natl Acad Sci USA, 87, 8296-300.
8. Chen W-T, Lee C-C, Goldstein L, et al. 1994, Membrane proteases as potential diagnostic and therapeutic targets for breast malignancy. Breast Cancer Res Treat, 31, 217-26.
9. Coopman PJ, Thomas DM, Gehlsen KR and Mueller SC, 1996, Integrin α3β1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol Biol Cell, 7, 1789-804.
10. Monsky WL and Chen W-T, 1993, Proteases of cell adhesion proteins in cancer. Semin Cancer Biol, 4, 251-8.
11. r 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res, 53, 3159-64.
12. Nakahara H, Howard L, Thompson EW, et al. 1997, Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA, 94, 7959-64.
13. Pei D and Weiss SJ, 1996, Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem, 271, 9135-40.
14. Imai K, Ohuchi E, Aoki T, et al. 1996, Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in complex with tissue inhibitor of metalloproteinases 2. Cancer Res, 56, 2707-10.
15. Strongin AY, Collier I, Bannikov G, et al. 1995, Mechanism of cell surface activation of 72 kDa type IV collagenase. J Biol Chem, 270, 5331-38.
16. Sato H, Takino T, Okada Y, et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370, 61-5.
17. Thompson EW, Paik S, Brunner N, et al. 1992, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol, 150, 534-44.
18. Moll UM, Lane B, Zucker S, et al. 1990, Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line. Cancer Res, 50, 6995-7002.
19. Davis GE and Martin BM, 1990, A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes. Cancer Res, 50, 1113-20.
20. Deutsch DG and Mertz ET, 1970, Plasminogen: purification from human plasma by affinity chromatography. Science, 170, 1095-6.
21. Hunter WM and Greenwood FC, 1962, Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature, 194, 495-6.
22. Monsky WL, Lin C-Y, et al. 1994, A potential marker protease of invasiveness, seprase, is localized to invadopodia of human malignant melanoma cells. Cancer Res, 54, 5702-10.
23. Harlow E and Lane D, 1988, Antibodies: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
24. Heussen C and Dowdle EB, 1980, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem, 102, 196-202.
25. Liebersbach BF and Sanderson RD, 1994, Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem, 269, 20013-19.
26. Brown PD and Giavazzi R, 1995, Matrix metalloproteinase inhibition: a review of anti-tumour activity. Annals Oncol, 6, 967-74.
27. Davies B, Brown PD, East N, et al. 1993, A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res, 53, 2087-91.
28. Sledge GW, Jr. Qulali M, Goulet R, et al. 1995, Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice. J Natl Cancer Inst, 87, 1546-50.
29. Goldberg GI, Frisch SM, He C, et al. 1990, Secreted proteases. Regulation of their activity and their possible role in metastasis. Ann NY Acad Sci, 580, 375-84.
30. Brown PD, Bloxidge RE, Anderson E and Howell A, 1993, Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Met, 11, 183-9.
31. Davies B, Miles DW, Happerfield LC, et al. 1993, Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer, 67, 1126-31.
32. Iwata H, Kobayashi S, Iwase H, et al. 1996, Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jap J Cancer Res, 87, 602-11.
33. Basset P, Wolf C and Chambon P, 1993. Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat, 24, 185-93.
34. Shi YE, Torri J, Yieh L, et al. 1993, Identification and characterization of a novel matrix-degrading protease from hormone dependent human breast cancer cells. Cancer Res, 53, 1409-15.
35. Ueno H, Nakamura H, Inoue M, et al. 1997, Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res, 57, 2055-60.
36. Eccles SA, Box GM, Court WJ, et al. 1996, Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res, 56, 2815-22.
37. Wojtowicz-Praga S, Low J, Marshall J, et al. 1996, Phase I trial of a novel matrix metalloproteinase inhibitor batimastat (BB-94) in patients with advanced cancer. Invest New Drugs, 14, 193-202.
38. Malfetano J, Teng N, Moore D, et al. 1996, Marimastat, a novel matrix metalloproteinase inhibitor in patients with advanced cancer of the ovary: a dose-finding study. Proc Am Clin Oncol, 764.
39. Stonelake PS, Jones CE, Neoptolemos JP and Baker PR, 1997, Proteinase inhibitors reduce basement membrane degradation by human breast cancer cell lines. Br J Cancer, 75, 951-9.
40. Sato H, Takino T, Kinoshita T, et al. 1996, Cell surface binding and activation of gelatinase A induced by expression of membrane type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett, 385, 238-40.
41. Brooks PC, Stromblad S, Sanders LC, et al. 1996, Localization of matrix metalloproteinase-2 to the surface of invasive cells by interaction with integrin αVβ3. Cell, 85, 683-93.
42. Nakahara H, Nomizu M, Akiyama SK, et al. 1996, A mechanism for regulation of melanoma invasion. J Biol Chem, 271, 27221-4.